The analgesic drug market is one of the largest segments of the healthcare industry. The chronic pain drugs market offers a high growth opportunity to pharmaceutical companies. The U.S. represents the largest market for the analgesic drugs worldwide; there are more than 100 million people suffering from the chronic pain.
Further, the Asia-Pacific is a fast growing market for analgesic drugs, and this market is expected to grow 4% annually. Among the painkilling drugs, Pfizer (PFE) is working on developing "Remoxy," an investigational analgesic drug that was rejected twice by the FDA. Read more. PFE.
No comments:
Post a Comment